Date
Therapeutic and Clinical Areas
Topics
Content Type
Asset Type
Product Brands
Product Families
Product Categories
Product Line
Showing 1 to 10 of 1135 results
- LAST UPDATE: Mar 13, 2025Customer Support
- LAST UPDATE: Mar 13, 2025FAQBy combining BD HealthSight™ Inventory Optimization and BD Pyxis™ Logistics, you can gain—and sustain—better visibility and insights
- LAST UPDATE: Mar 13, 2025FAQThis FAQ answers questions on our pain management portfolio, which consists of our Alaris™ PCA, EtCO and SpO modules.
- LAST UPDATE: Mar 13, 2025Case StudyCase study of how ARH standardized their pharmacy services by integrating technologies to enhance visibility and streamline workflows.
- LAST UPDATE: Mar 13, 2025Patient EducationChronic venous disease treatment options for your patients. (ppt)
- LAST UPDATE: Mar 13, 2025Patient EducationChronic venous disease treatment options for your patients. (PDF)
- LAST UPDATE: Mar 13, 2025BrochureManage recurrent malignant and non-malignant ascites, at home.
- LAST UPDATE: Mar 12, 2025Product Demonstration ComplianceBD’s Real World Testing method involved measuring our ability to successfully deliver our clients’ AUR reports to NHSN. In calendar year 2024, customers were able to successfully report AUR data to NSHN via the AUR Reporting Module. The total number of successes and NSHN issues resolved were tracked on AUR reports and submitted by BD clients monthly. By measuring successful report submission, we demonstrated that our clients can use our software for AUR reporting and thus improve the speed and accuracy of NHSN reporting.
- LAST UPDATE: Mar 11, 2025Brochure3D shapes designed to maximize your visualization without the need for polymers or gels.
- LAST UPDATE: Mar 07, 2025DocumentThe BD products listed below may be covered by one or more of the identified patents. These lists are provided to satisfy the virtual marking provisions of the America Invents Act (35 USC 287). The content of these lists and association between products and patents may change due to events including, but not limited to: filing, publication, issuance, licensing, product changes, expiration, abandonment, and other circumstances.